Variant report
Variant | nsv609994 |
---|---|
Chromosome Location | chr8:6155658-6171324 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6145627..6147844-chr8:6162410..6164202,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12679001 | chr8:6155658-6155659 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs572770484 | chr8:6155672-6155673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs61481450 | chr8:6155691-6155692 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs536681212 | chr8:6155698-6155699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12681204 | chr8:6155715-6155716 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs140558054 | chr8:6155756-6155757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545057096 | chr8:6155804-6155805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117040678 | chr8:6155811-6155812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376377111 | chr8:6155812-6155813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575402782 | chr8:6155845-6155846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369930574 | chr8:6155858-6155859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150421382 | chr8:6155873-6155874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549725247 | chr8:6155874-6155875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562955608 | chr8:6155880-6155881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77208506 | chr8:6155901-6155902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530306304 | chr8:6155918-6155919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549008384 | chr8:6155968-6155969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559047354 | chr8:6155975-6155976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138218860 | chr8:6155979-6155980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551473358 | chr8:6155982-6155983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571483466 | chr8:6155995-6155996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202183218 | chr8:6155998-6155999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs199888804 | chr8:6156016-6156017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144343763 | chr8:6156025-6156026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75431692 | chr8:6156029-6156030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371912807 | chr8:6156033-6156034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377062208 | chr8:6156049-6156050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537279354 | chr8:6156060-6156061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550776594 | chr8:6156062-6156063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184066968 | chr8:6156069-6156070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536149262 | chr8:6156088-6156089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149551871 | chr8:6156091-6156092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573106454 | chr8:6156122-6156123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539731787 | chr8:6156130-6156131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs117414423 | chr8:6156151-6156152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188854508 | chr8:6156192-6156193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181653027 | chr8:6156193-6156194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146349226 | chr8:6156227-6156228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575116281 | chr8:6156252-6156253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548041363 | chr8:6156274-6156275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540524873 | chr8:6156281-6156282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200672071 | chr8:6156287-6156288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559323181 | chr8:6156300-6156301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528041222 | chr8:6156301-6156302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545005178 | chr8:6156314-6156315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567876929 | chr8:6156324-6156325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563424122 | chr8:6156329-6156330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550837302 | chr8:6156347-6156348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558027064 | chr8:6156372-6156373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530002941 | chr8:6156389-6156390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6154400-6158200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr8:6154400-6158200 | Weak transcription | Osteobl | bone |
3 | chr8:6158200-6158400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr8:6158200-6160200 | Enhancers | Osteobl | bone |
5 | chr8:6158400-6158800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr8:6158800-6159200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr8:6160000-6160200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr8:6160200-6161200 | Weak transcription | Osteobl | bone |
9 | chr8:6160200-6167400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr8:6161000-6162200 | Enhancers | Brain Germinal Matrix | brain |
11 | chr8:6161200-6161800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr8:6161200-6164000 | Enhancers | Osteobl | bone |
13 | chr8:6162400-6162600 | Enhancers | NH-A | brain |
14 | chr8:6162600-6163200 | Weak transcription | NH-A | brain |
15 | chr8:6163200-6164000 | Enhancers | NH-A | brain |
16 | chr8:6164000-6168800 | Weak transcription | Osteobl | bone |
17 | chr8:6165600-6166000 | Enhancers | Spleen | Spleen |
18 | chr8:6166000-6169000 | Weak transcription | Spleen | Spleen |
19 | chr8:6167400-6167600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr8:6168400-6169600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
21 | chr8:6168800-6169400 | Enhancers | Osteobl | bone |
22 | chr8:6169000-6169200 | Enhancers | A549 | lung |
23 | chr8:6169400-6170800 | Weak transcription | Osteobl | bone |
24 | chr8:6170600-6170800 | Active TSS | A549 | lung |
25 | chr8:6170800-6171600 | Flanking Active TSS | A549 | lung |
26 | chr8:6170800-6171600 | Enhancers | Osteobl | bone |
27 | chr8:6171000-6171400 | Bivalent Enhancer | HepG2 | liver |